other material
confidence high
sentiment neutral
materiality 0.40
Traws Pharma amends Series A warrant terms for certain holders
Traws Pharma, Inc.
- Increases change-of-control threshold from 50% to >50% in Fundamental Transaction definition.
- Revises expected volatility rate for Black Scholes Value calculation in warrant valuation.
- Removes Section 3(h) which adjusted exercise price on reverse stock split events.
- Series A Warrants originally issued Dec 29, 2024 as part of Class A and Class B Units.